An apparent clinical pharmacokinetic drug-drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism.
about
An apparent clinical pharmacokinetic drug-drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
An apparent clinical pharmacok ...... a a target-trapping mechanism.
@en
type
label
An apparent clinical pharmacok ...... a a target-trapping mechanism.
@en
prefLabel
An apparent clinical pharmacok ...... a a target-trapping mechanism.
@en
P2093
P2860
P1476
An apparent clinical pharmacok ...... a a target-trapping mechanism.
@en
P2093
Angelika Lahr
Eginhard Schick
Franziska Schaedeli Stark
Jean Tessier
Jianguo Zhi
Kai Habben
Oliver Krieter
Roland F Staack
Tilman Schlothauer
P2860
P2888
P304
P356
10.1007/S00280-017-3242-8
P577
2017-03-17T00:00:00Z
P6179
1084020488